in Business

23andMe Lays Off 40% of Staff, Shuts Drug Development Business

338 Views

23andMe Lays Off 40% of Staff, Shuts Drug Development Business




The genetics firm is closing a unit that was as soon as seen as core to its future.

Report

Comments

Express your views here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Disqus Shortname not set. Please check settings

Written by EGN NEWS DESK

Rita Ora Pays Tribute to Liam Payne: “He Had the Biggest Heart”

Rita Ora Pays Tribute to Liam Payne: “He Had the Biggest Heart”
NASA releases UFO report. Here’s what they discovered

NASA releases UFO report. Here’s what they discovered